This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeshima, E.
Right arrow Articles by Mori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeshima, E.
Right arrow Articles by Mori, N.

 Previous Article  |  Next Article 

Infection and Immunity, April 2009, p. 1337-1348, Vol. 77, No. 4
0019-9567/09/$08.00+0     doi:10.1128/IAI.01456-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Helicobacter pylori-Induced Interleukin-12 p40 Expression{triangledown}

Eriko Takeshima,1,2 Koh Tomimori,1,2 Hiromitsu Teruya,1,2 Chie Ishikawa,1,3 Masachika Senba,4 Daniele D'Ambrosio,5 Fukunori Kinjo,6 Hitomi Mimuro,7 Chihiro Sasakawa,7 Toshiya Hirayama,8 Jiro Fujita,2 and Naoki Mori1*

Divisions of Molecular Virology and Oncology,1 Control and Prevention of Infectious Diseases,2 Graduate School of Medicine, Division of Child Health and Welfare, Faculty of Medicine,3 Department of Endoscopy, University Hospital, University of the Ryukyus, Nishihara, Okinawa 903-0215, Japan,6 Departments of Pathology,4 Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan,8 Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan,7 BioXell SpA, Milan, Italy5

Received 28 November 2008/ Returned for modification 6 January 2009/ Accepted 21 January 2009


arrow
ABSTRACT
 
Interleukin-12 (IL-12) is a heterodimeric cytokine produced by antigen-presenting cells that promotes the development of T-helper lymphocyte 1 (Th1). Chronic gastritis induced by Helicobacter pylori is considered a Th1-mediated process. IL-12 levels in gastric biopsy samples of H. pylori-infected patients are higher than in those of uninfected individuals, but the cellular source of IL-12 remains elusive. IL-12 staining was detected in mucosal epithelial cells, lymphocytes, and macrophages in specimens of patients with H. pylori-positive gastritis. Therefore, we investigated IL-12 p40 mRNA induction by H. pylori in gastric epithelial cells and T cells. Although cag pathogenicity island (PAI)-positive H. pylori induced IL-12 p40 mRNA expression, an isogenic mutant of the cag PAI failed to induce it in both cell types. Supernatants from H. pylori cultures and H. pylori VacA induced IL-12 p40 mRNA expression in T cells but not in epithelial cells. The activation of the IL-12 p40 promoter by H. pylori was mediated through NF-{kappa}B. The transfection of I{kappa}B kinase and NF-{kappa}B-inducing kinase dominant-negative mutants inhibited H. pylori-induced IL-12 p40 activation. Inhibitors of NF-{kappa}B, phosphatidylinositol 3-kinase, p38 mitogen-activated protein kinase, and Hsp90 suppressed H. pylori- and VacA-induced IL-12 p40 mRNA expression. The results indicate that H. pylori induces IL-12 p40 expression by the activation of NF-{kappa}B, phosphatidylinositol 3-kinase, and p38 mitogen-activated protein kinase. Hsp90 is also a crucial regulator of H. pylori-induced IL-12 p40 expression. In addition to the cag PAI, VacA might be relevant in the induction of IL-12 expression and a Th1-polarized response only in T cells.


arrow
INTRODUCTION
 
Helicobacter pylori is a gram-negative, spiral-shaped, microaerophilic bacterial pathogen found in the gastric mucosa of >50% of the world population. In 10 to 20% of infected individuals, the H. pylori-induced chronic gastric inflammation progresses to peptic ulcer, gastric cancer, or gastric mucosa-associated lymphoid tissue lymphoma (22, 23, 55). Despite the development of immune responses against H. pylori infection, the bacteria are rarely eliminated, and colonization generally is persistent. Factors that contribute to the failure of the immune response to clear the organism remain elusive (2). Bacterial, environmental, and host genetic factors may affect the progress and outcome of gastric disease. One such factor responsible for severe disease is the virulence of individual H. pylori strains. Several virulence factors have been described and include the presence of a cag pathogenicity island (PAI) and vacuolating cytotoxin (VacA) (11, 42, 46). H. pylori strains that carry cag PAI genes, called type I strains, are highly prevalent in patients with peptic ulcers and gastric cancer (4, 9, 13). H. pylori strains that express higher levels of VacA activity correlate with an increased severity of gastritis (26, 30, 51). VacA has been reported to have immunosuppressive activity, including the inhibition of T-cell proliferation (5, 18). However, VacA also has proinflammatory activities in immune cells (40, 56).

There is abundant evidence that T lymphocytes play a pivotal role in the pathogenesis of H. pylori-induced chronic gastric inflammation (50). This pathological state is considered a T-helper lymphocyte 1 (Th1)-mediated process characterized by the increased production of gamma interferon (IFN-{gamma}), which is implicated in perpetuating the inflammatory changes that lead to disease (15, 29). Interleukin-12 (IL-12) is a heterodimeric molecule (p70) consisting of a heavy chain (p40) and a light chain (p35) that promotes the development of Th1 cells and stimulates proliferation, cytolytic activity, and IFN-{gamma} production by T and natural killer cells (8, 38). The expression of the p40 gene is specific to IL-12-producing cells, while p35 gene expression is constitutively expressed in different cell types.

Although antigen-presenting cells such as macrophages and dendritic cells are the primary producers of IL-12 p40 after microbial challenge (58), we have found that H. pylori induces the expression of IL-12 p40 in both gastric epithelial cells and T cells in this study. We analyzed the molecular mechanism of H. pylori-mediated IL-12 p40 induction in the gastric epithelial cell lines MKN45, MKN28, and AGS and in a T-cell line, Jurkat, and in isolated CD4+ T cells. Although cag PAI-positive H. pylori induced IL-12 p40 mRNA expression, an isogenic mutant of cag PAI failed to induce it in both cell types. The results showed that H. pylori induced IL-12 p40 expression by activating NF-{kappa}B. Hsp90 acted as a crucial regulator in H. pylori-induced IL-12 p40 expression. Our results also indicate that the mechanism of IL-12 p40 induction is different in the two cell types and that H. pylori-mediated IL-12 p40 induction in T cells involves both the cag PAI and VacA.


arrow
MATERIALS AND METHODS
 
Antibodies and reagents. Mouse monoclonal antibodies to IL-12 and IL-23 were purchased from R&D Systems (Minneapolis, MN) and BioLegend (San Diego, CA), respectively. Rabbit polyclonal antibodies to phospho-Akt (Thr-308), phospho-Akt (Ser-473), and NF-{kappa}B subunits p50, p65, c-Rel, p52, and RelB were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal antibody to actin was purchased from NeoMarkers (Fremont, CA). Mouse monoclonal antibody to phospho-I{kappa}B{alpha} (Ser-32 and Ser-36) and rabbit polyclonal antibodies to p38 and phospho-p38 (Thr-180 and Tyr-182) were purchased from Cell Signaling Technology (Beverly, MA). IL-1{alpha} and tumor necrosis factor {alpha} (TNF-{alpha}) were purchased from Peprotech EC, Inc. (London, United Kingdom). N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) and Bay 11-7082 were purchased from Sigma-Aldrich and Calbiochem (La Jolla, CA), respectively. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) was purchased from Alomone Labs (Jerusalem, Israel). The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and p38 inhibitor SB203580 were obtained from Calbiochem (La Jolla, CA).

Bacterial strains. H. pylori ATCC 49503 (American Type Culture Collection, Rockville, MD) was used in most experiments described in this study. An isogenic H. pylori mutant lacking the cag PAI (1) or VacA also was studied together with their parental wild-type strain (26695). For the generation of the vacA (hp0887) deletion mutant of H. pylori 26695, the vacA upstream sequence was amplified with an F1 (forward) primer containing an XhoI site and an R1 (reverse) primer containing an SmaI site and was cloned in pBluescript II (Stratagene, La Jolla, CA), resulting in plasmid pVacAu. The vacA downstream sequence, which was amplified with the F2 primer containing an SmaI site and the R2 primer containing BamHI site, was cloned in pVacAu, yielding plasmid pVacAud. The aphA-3 (the kanamycin resistance gene) cassette, specifically designed for the construction of nonpolar mutants (39), was ligated between the fragments at the SmaI site of pVacAud in the correct orientation, resulting in plasmid pVacAdel. The transformants were grown on 5% sheep blood agar plates supplemented with 4 µg/ml kanamycin. The resulting kanamycin-resistant transformants were analyzed for the formation of vacuoles on the infected AGS cells, and the location of the aphA-3 gene was analyzed by PCR. The sequences of the primers are as follows: F1, 5'-CCGCTCGAGCTTTAATCCTTCGCAAGTCTTTTCGC; R1, 5'-TCCCCCGGGGCGCCAAACTTTATCGGGTTTATCTG; F2, 5'-TCCCCCGGGTATTATTATGGGGACACTTC; and R2, 5'-CGGGATCCATGGCGATAGCGGTAGTGGAGT. H. pylori strains were plated on blood agar plates and incubated at 37°C for 2 days under microaerophilic conditions. Using inoculating needles, bacteria harvested from the plates were suspended in 50 ml of brucella broth containing 5% fetal bovine serum (FBS) and then cultured in a liquid medium at 37°C for 1 day in a controlled microaerophilic environment. Bacteria were harvested from the broth culture by centrifugation and then resuspended at the concentrations indicated below in antibiotic-free medium. All procedures were performed with the approval of the appropriate institutional biosafety review committees and in compliance with their guidelines for biohazards.

Purification of VacA. ATCC 49503 was the source of VacA for purification as described previously (43). Purified VacA was activated immediately before use on cells. The acid activation of VacA was accomplished by the dropwise addition of HCl to the purified toxin.

Cell culture. Human gastric epithelial cells (MKN45, MKN28, and AGS) and T cells (Jurkat) were maintained in RPMI 1640 medium containing 10% FBS, 100 U/ml penicillin G, and 100 µg/ml streptomycin. Human peripheral blood mononuclear cells were isolated from the peripheral blood of healthy donors using Ficoll-Hypaque gradients. Peripheral blood mononuclear cells then were further purified using positive selection with immunomagnetic beads specific for CD4 (Miltenyi Biotec, Auburn, CA). On the day of the experiment, cells were refed with fresh antibiotic-free medium and cocultured with H. pylori for the time intervals indicated below.

Tissue samples. Five histopathologically normal stomach biopsy specimens from control patients that underwent esophagogastroscopy for other reasons and stomach biopsy specimens from five patients with H. pylori gastritis were used for reverse transcription-PCR (RT-PCR) analysis and examined histopathologically for IL-12. The presence of H. pylori infection was confirmed by culture, serological analysis (with anti-H. pylori immunoglobulin G antibody), a rapid urease test, and histological visualization with Giemsa staining. Patients with H. pylori gastritis showed polymorphonuclear neutrophil infiltration in the gastric epithelium in conjunction with the presence of bacterial forms, which is consistent with H. pylori infection. All samples were obtained after informed consent was received from the subjects.

RT-PCR. Total cellular RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA) according to the protocol provided by the manufacturer. First-strand cDNA was synthesized from 1 µg total cellular RNA using an RNA PCR kit (Takara Bio Inc., Otsu, Japan) with random primers. Thereafter, cDNA was amplified using 35 and 28 cycles for IL-12 p40 and for β-actin, respectively. The specific primers used were as follows: for IL-12 p40, 5'-CATTCGCTCCTGCTGCTTCAC-3' (forward primer) and 5'-TACTCCTTGTTGTCCCCTCTG-3' (reverse primer); for β-actin, 5'-GTGGGGCGCCCCAGGCACCA-3' (forward primer) and 5'-CTCCTTAATGTCACGCACGATTTC-3' (reverse primer). The product sizes were 267 bp for IL-12 p40 and 548 bp for β-actin. The thermocycling conditions for the targets were as follows: 94°C for 30 s, 60°C for 30 s, and 72°C for 90 s. The PCR products were fractionated on 2% agarose gels and visualized by ethidium bromide staining.

Plasmids. The I{kappa}B{alpha}{Delta}N and I{kappa}Bβ{Delta}N dominant-negative mutants (kindly provided by D. W. Ballard, Vanderbilt University School of Medicine, Nashville, TN) are I{kappa}B{alpha} and I{kappa}Bβ deletion mutants lacking the NH2-terminal 36 and 23 amino acids, respectively (6, 37). The IKK{alpha} dominant-negative mutant IKK{alpha} (K44M) and the IKKβ dominant-negative mutant IKKβ (K44A), as well as the NF-{kappa}B-inducing kinase (NIK) dominant-negative mutant NIK (KK429/430AA), have been described previously (19). The IL-12 p40 promoter pXP2 luciferase reporter plasmid containing the wild-type sequence (position –292 to position +56) or the internal deletion mutant of the NF-{kappa}B site was used to map H. pylori-responsive regions (14). To construct the human p40 promoter/luciferase reporter construct, we generated p40 promoter fragments by the PCR of genomic DNA obtained from THP-1 cells. The resulting PCR products were ligated in pCR II (Invitrogen) and subsequently excised and religated in BamHI/XhoI sites of the pXP2 luciferase vector. To create the internal deletion of the NF-{kappa}B site, a PCR product extending from –106 to +56 bp was ligated in BamHI/XhoI sites of pXP2. Subsequently, a second PCR product extending from –111 to –292 bp and flanked by BamHI sites was ligated into the BamHI site of the –106/+56 p40-pXP2 vector.

Transfection and luciferase assay. MKN45 cells were transfected with 1 µg of the appropriate reporter and 2 µg of effector plasmids using Lipofectamine (Invitrogen). Jurkat cells also were transfected with 10 µg of the reporter plasmid using electroporation. After 24 h, H. pylori was added and incubated for 6 h. The ratio of bacteria to cells (i.e., the multiplicity of infection [MOI]) was 20:1. The cells were washed in phosphate-buffered saline (PBS) and lysed in reporter lysis buffer (Promega, Madison, WI). Lysates were assayed for reporter gene activity with the dual-luciferase assay system (Promega). Luciferase activities were normalized relative to the Renilla luciferase activity from phRL-TK.

Preparation of nuclear extracts and EMSA. NF-{kappa}B binding activity with the NF-{kappa}B element was examined by electrophoretic mobility shift assay (EMSA) as described previously (41). To examine the specificity of the NF-{kappa}B element probe, we preincubated unlabeled competitor oligonucleotides with nuclear extracts for 15 min before incubation with probe. The probe or competitors used were prepared by annealing the sense and antisense synthetic oligonucleotides as follows: for the NF-{kappa}B element of the IL-12 p40 gene, 5'-GATCCTTGAAATTCCCCCAG-3'; for the NF-{kappa}B element of the IL-2 receptor {alpha}-chain (IL-2R{alpha}) gene, 5'-GATCCGGCAGGGGAATCTCCCTCTC-3'; and for the AP-1 element of the IL-8 gene, 5'-GATCGTGATGACTCAGGTT-3'. The oligonucleotide 5'-GATCTGTCGAATGCAAATCACTAGAA-3', containing the consensus sequence of the octamer binding motif, was used to identify specific binding of the transcription factor Oct-1. The above underlined sequences are the NF-{kappa}B, AP-1, and Oct-1 binding sites, respectively. To identify NF-{kappa}B proteins in the DNA-protein complex shown by EMSA, we used antibodies specific for various NF-{kappa}B family proteins, including p50, p65, c-Rel, p52, and RelB, to elicit a supershift DNA-protein complex formation. These antibodies were incubated with the nuclear extracts for 45 min at room temperature before incubation with radiolabeled probe.

Western blot analysis. Cells were lysed in a buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate, 10% glycerol, 6% 2-mercaptoethanol, and 0.01% bromophenol blue. Equal amounts of protein (20 µg) were subjected to electrophoresis on sodium dodecyl sulfate-polyacrylamide gels, followed by transfer to a polyvinylidene difluoride membrane and sequential probing with the specific antibodies. The bands were visualized with an enhanced chemiluminescence kit (Amersham Biosciences, Piscataway, NJ).

IL-12 p40, IL-12 p70, and IL-23 measurements. The IL-12 p40, IL-12 p70, and IL-23 contents in the culture supernatants were measured by enzyme-linked immunosorbent assay (ELISA) (Biosource International, Camarillo, CA). MKN45 and AGS cells were cultured in RPMI 1640 supplemented with 10% FBS in 24-well plates. Subconfluent monolayers of cells were cocultured with H. pylori for 24 h. The supernatants then were collected after centrifugation to remove bacteria and stored at –80°C until they were assayed for IL-12 p40, IL-12 p70, and IL-23 by ELISA. The concentrations of these cytokines were determined using a standard curve constructed with recombinant cytokines.

Immunohistochemical analysis. Serial sections were deparaffinized in xylene and dehydrated using a graded ethanol series. For better detection, sections were pretreated with ready-to-use proteinase K (Dako, Inc., Carpinteria, CA) for 10 min at 37°C. This procedure increased the number of antigenic sites available for binding by the antibody. Sections were washed four times in PBS for 5 min each. In the next step, the tissues were placed in 3% hydrogen peroxide and absolute methanol for 5 min to reduce endogenous peroxidase activity, followed by four washings in PBS for 5 min each. The tissue sections were incubated with mouse anti-human IL-12 (1:100) or anti-human IL-23 monoclonal antibody (1:100) or a control mouse immunoglobulin G for 3 h at 37°C. After four washings with PBS for 5 min each, the sections were covered with EnVision plus (Dako, Santa Barbara, CA) for 40 min at 37°C and washed four times in PBS for 5 min each. Antigenic sites bound by the antibody were identified by reacting the sections with a mixture of 0.05% 3,3'-diaminobenzidine tetrahydrochloride in 50 mM Tris-HCl buffer and 0.01% hydrogen peroxide for 7 min. Sections were washed three times in distilled water for 5 min each and then counterstained with methyl green for 10 min, hydrated in ethanol, cleaned in xylene, and mounted. The stained cells were examined using light microscopy. Gastric epithelial cells, lymphocytes, and macrophages were identified morphologically.

Statistical analysis. Data were analyzed by using the Student t test. P values of <0.05 were considered significant.


arrow
RESULTS
 
Increased expression of IL-12 p40 in gastric mucosa of patients with H. pylori gastritis. RT-PCR showed the presence of IL-12 p40 transcripts in specimens of patients with H. pylori gastritis (n = 2) (Fig. 1A). The analysis of H. pylori-negative control specimens (n = 2) showed undetectable levels of IL-12 p40 mRNA. We also investigated the presence of IL-12 protein in H. pylori-positive gastric diseases and determined its cellular source. For this purpose, we immunostained H. pylori-positive gastritis tissues (n = 5). Interestingly, IL-12 staining was detected in mucosal epithelial cells (Fig. 1B to D) and lymphocytes as well as macrophages (Fig. 1E). This antibody shows no cross-reactivity with the IL-12 p40 homodimer or with IL-23. Therefore, the biologically active heterodimeric IL-12 p70 was detected in inflamed H. pylori gastritis tissues. In contrast, only a faint staining for IL-12 was detected in the normal mucosa, but the level of its expression was much weaker than that in H. pylori-positive gastritis tissues (Fig. 1F and G). A p19 protein was identified that combines with IL-12 p40 to form IL-23, with functions that are similar but discrete from those of IL-12 (32). We also investigated whether IL-23 protein was increased in H. pylori-positive gastritis tissues. IL-23 staining also was detected in epithelial cells (Fig. 1H), macrophages, and lymphocytes (Fig. 1I) of specimens of H. pylori-positive gastritis. In contrast, IL-23 staining was not detected in the normal mucosa (Fig. 1J and K).


Figure 1
View larger version (94K):
[in this window]
[in a new window]

  		FIG. 1. Expression of IL-12 p40 in H. pylori-infected gastric mucosa. (A) RT-PCR analysis of IL-12 p40 in representative human gastric tissues. Lanes 1 and 2, normal mucosa; lanes 3 and 4, H. pylori-positive gastritis; lane M, markers. β-Actin expression served as a control. Immunohistochemical detection of IL-12 (B to G) and IL-23 (H to K) in tissues of patients with H. pylori-positive gastritis. Serial sections of gastric biopsy specimens were stained with mouse monoclonal antibodies to IL-12 and IL-23 and counterstained with methyl green. Also shown are representative examples of mucosa from patients with H. pylori-positive gastritis (B to E, H, and I) and normal mucosa (F, G, J, and K). Note the positive staining for IL-12 and IL-23 in epithelial cells and lymphocytes as well as macrophages from patients with H. pylori-positive gastritis. (B to D and F) Original magnification, x170. (E and G) Original magnification, x430. (H, J, and K) Original magnification, x140. (I) Original magnification, x360. The white, black, and red arrows indicate the surfaces of epithelial cells, lymphocytes, and macrophages, respectively. The asterisks indicate deeper structures of epithelial cells.

H. pylori increases IL-12 p40 mRNA levels in gastric epithelial cells. Using RT-PCR, we next examined whether the coculture of the gastric epithelial cell lines MKN45, MKN28, and AGS with H. pylori results in the induction of IL-12 p40 mRNA. Coculture with H. pylori significantly enhanced the steady-state levels of IL-12 p40 mRNA in all three cell lines (Fig. 2A). IL-12 p40 transcript levels clearly increased 2 h after the addition of H. pylori to MKN45 cells (Fig. 2A). In the next step, we examined whether IL-12 p40 was secreted into the culture media of MKN45 and AGS cells cocultured with H. pylori. ELISA indicated that IL-12 p40 was secreted into the media of MKN45 and AGS cells cocultured with H. pylori during a 24-h period (Fig. 2B). IL-12 p70 also was secreted into the media of MKN45 cells cocultured with H. pylori. However, IL-23 was not secreted (data not shown).


Figure 2
View larger version (32K):
[in this window]
[in a new window]

  		FIG. 2. H. pylori-induced IL-12 p40 mRNA expression and secretion in gastric epithelial cells. (A) Dynamics of H. pylori-induced IL-12 p40 mRNA expression. Total RNA was extracted from the indicated cells that had been infected with H. pylori ATCC 49503 for the indicated times and used for RT-PCR (MOI, 20). Representative results of three similar experiments in each panel are shown. M, size marker. (B) Increased secretion of IL-12 p40 and p70 into the supernatants of MKN45 and AGS cell cultures in response to H. pylori ATCC49503 infection at 24 h. IL-12 p40 and p70 concentrations in the supernatants were determined by ELISA. Data are means ± standard deviations from three experiments. **, P < 0.01, as determined by the Student t test. (C) Expression of IL-12 p40 mRNA was further upregulated in response to H. pylori when there was stimulation by the proinflammatory cytokines IL-1{alpha} and TNF-{alpha} in MKN45 cells. MKN45 cells were stimulated with IL-1{alpha} (100 ng/ml) or TNF-{alpha} (100 ng/ml) for 12 h and then incubated in the presence or absence of H. pylori for 2 h, and the expression of IL-12 p40 mRNA was assessed by RT-PCR. Representative results from three similar experiments are shown in each panel.

The levels of production of IL-1 and TNF-{alpha} were reported to be significantly higher in mucosa of H. pylori-positive patients than in normal mucosa (44). Because previous studies have shown that proinflammatory cytokines alter the expression of other cytokines, we further investigated whether gastric epithelial cells respond to H. pylori and proinflammatory cytokines to induce IL-12 p40 expression. MKN45 cells were stimulated with IL-1{alpha}, IL-8, or TNF-{alpha} alone for 12 h and then infected with H. pylori. The results in Fig. 2C demonstrate that the proinflammatory cytokines IL-1{alpha} and TNF-{alpha} induced MKN45 cells to express IL-12 p40, and the expression of IL-12 p40 was further upregulated in response to H. pylori when there was stimulation by IL-1{alpha} and TNF-{alpha}. In contrast, IL-8 failed to induce IL-12 p40 expression (data not shown).

H. pylori-induced IL-12 p40 mRNA expression is cag PAI dependent. Recent studies indicated that the expression of multiple genes in the cag PAI is necessary for cytokine production in gastric epithelial cells in vitro (9, 59). Accordingly, we examined the abilities of a wild-type cag PAI-positive H. pylori strain (26695) and an isogenic cag PAI mutant ({Delta}cag PAI) to induce IL-12 p40 mRNA expression. Infection with wild-type strain 26695 induced IL-12 p40 mRNA expression in MKN45 and MKN28 cells, while the isogenic mutant that lacked cag PAI expression did not induce IL-12 p40 mRNA expression (Fig. 3A). These results suggest that the H. pylori cag PAI plays an important role in the induction of IL-12 p40 mRNA expression.


Figure 3
View larger version (27K):
[in this window]
[in a new window]

  		FIG. 3. cag PAI products of H. pylori are required for the induction of IL-12 p40 mRNA expression. (A) Total RNA was extracted from the indicated cells that had been infected with the wild-type strain 26695 (WT) or the isogenic mutant {Delta}cag PAI ({Delta}cag) for the indicated times and used for RT-PCR. Representative results of three similar experiments are shown in each panel. M, size marker. (B) H. pylori infection increased IL-12 p40 promoter activity in a dose-dependent fashion. A luciferase (LUC) reporter construct was transfected into MKN45 and AGS cells, and the cells subsequently were infected with the WT or {Delta}cag PAI for 6 h. The activities are expressed relative to that of cells transfected with the reporter construct without further H. pylori infection, which was defined as 1. Data are means ± standard deviations from three independent experiments. *, P < 0.05; **, P < 0.01; both were determined by the Student t test.

IL-12 p40 gene transcription regulated by H. pylori is cag PAI dependent. In the next series of experiments, we investigated whether the H. pylori-mediated upregulation of IL-12 p40 gene expression could directly enhance the activity of its promoter. MKN45 and AGS cells were transiently transfected with a reporter gene construct containing the segment from position –292 to position +56 of the IL-12 p40 upstream regulatory sequences. The coculture of wild-type strain 26695 resulted in a dose-dependent increase in the activity of this IL-12 p40-driven reporter construct (Fig. 3B). We further investigated the involvement of the cag PAI in the induction of IL-12 p40 promoter activity in MKN45 cells. The activation of the IL-12 p40-driven reporter was not observed by the isogenic mutant {Delta}cag PAI (Fig. 3B). These findings indicate that the cag PAI is required for the activation of the IL-12 p40 promoter.

NF-{kappa}B is essential for H. pylori-induced activation of the IL-12 p40 promoter. The NF-{kappa}B signaling pathway is activated in epithelial cells infected with cag PAI-positive H. pylori but not in cells infected with cag PAI-negative strains of H. pylori (17, 35, 54). To test the relative contribution of the NF-{kappa}B binding site to the H. pylori-mediated activation of IL-12 p40, the plasmid with an internal deletion mutant of this site of the IL-12 p40 promoter was transfected (Fig. 4). The deletion of the NF-{kappa}B binding site ({Delta}{kappa}B) abolished the H. pylori-mediated activation of this reporter construct. Therefore, the NF-{kappa}B binding site contributes to the activation of the IL-12 p40 promoter induced by H. pylori.


Figure 4
View larger version (10K):
[in this window]
[in a new window]

  		FIG. 4. H. pylori activates the IL-12 p40 promoter through the NF-{kappa}B binding site. (Left) Schematic diagram of the IL-12 p40 reporter constructs containing the wild type (–292) and internal deletion mutant of the NF-{kappa}B site ({Delta}{kappa}B). LUC, luciferase. (Right) Either the IL-12 p40 reporter construct or a construct bearing an internal deletion of the NF-{kappa}B binding site was transfected into MKN45 cells, and subsequently the cells were infected with H. pylori ATCC 49503 for 6 h (MOI, 20:1). The activity is expressed relative to that of cells transfected with each construct without further H. pylori infection, which was defined as 1. Data are means ± standard deviations from three independent experiments. *, P < 0.05, as determined by the Student t test.

H. pylori infection of gastric epithelial cells induces binding of NF-{kappa}B family proteins to the NF-{kappa}B element of the IL-12 p40 promoter. Because the internal deletional analysis of the IL-12 p40 promoter indicated that H. pylori infection activated transcription through the NF-{kappa}B site, it was important to identify the nuclear factors that bind to this site. The NF-{kappa}B sequence derived from the IL-12 p40 promoter was used as a probe in EMSA. MKN45, MKN28, and AGS cells were infected with H. pylori at different times after challenge, and nuclear protein extracts were prepared and analyzed to determine NF-{kappa}B DNA binding activity. As shown in Fig. 5A, a complex was induced in these cells within 10 min after infection with H. pylori and was detectable 180 min after infection. This NF-{kappa}B binding activity to the IL-12 p40 promoter was reduced by the addition of either cold probe or a typical NF-{kappa}B sequence derived from the IL-2R{alpha} enhancer but not by an oligonucleotide containing the AP-1 binding site (Fig. 5A, lanes 2 to 4). Next, we characterized the H. pylori-induced complexes identified by the IL-12 p40 NF-{kappa}B probe. These complexes were supershifted by the addition of anti-p50 or anti-p65 antibody (Fig. 5A, lanes 5 to 9), suggesting that H. pylori-induced IL-12 p40 NF-{kappa}B complexes are composed of p50 and p65. Based on these results, H. pylori infection seems to induce IL-12 p40 gene expression at least in part through the induced binding of p50 and p65 to the NF-{kappa}B site in the IL-12 p40 promoter region.


Figure 5
View larger version (82K):
[in this window]
[in a new window]

  		FIG. 5. H. pylori infection induces NF-{kappa}B binding activity. (A) Time course of NF-{kappa}B activation in MKN45, MKN28, and AGS cells infected with H. pylori, as evaluated by EMSA (left). Nuclear extracts from the indicated cells infected with H. pylori ATCC 49503 for the indicated times were mixed with 32P-labeled NF-{kappa}B probe (MOI, 20:1). Competition assays were performed with nuclear extracts from these cells infected with H. pylori ATCC 49503 for 30 min (right). Where indicated, 100-fold excess amounts of each specific competitor oligonucleotide were added to the reaction mixture with labeled probe NF-{kappa}B (lanes 2 to 4). A supershift assay of NF-{kappa}B DNA binding complexes in the same nuclear extracts also was performed. Where indicated, appropriate antibodies (Ab) were added to the reaction mixture before the addition of the 32P-labeled probe (lanes 5 to 9). Arrows indicate the specific complexes, while arrowheads indicate the DNA binding complexes supershifted by antibodies. (B) cag PAI products of H. pylori are required for the induction of NF-{kappa}B binding activity in MKN45 cells. Nuclear extracts from MKN45 cells infected with different densities (MOI) of wild-type strain 26695 or the isogenic mutant {Delta}cag PAI for 1 h were analyzed for NF-{kappa}B. Representative results of three similar experiments are shown in each panel. WT, wild type.

As described above, cag PAI-positive strains induced more IL-12 p40 mRNA than the cag PAI-negative H. pylori strain. We next determined whether cag PAI-positive H. pylori strains induce NF-{kappa}B more preferentially than its negative counterpart. Markedly increased NF-{kappa}B DNA binding activity was induced by wild-type strain 26695 compared to that induced by the isogenic cag PAI mutant (Fig. 5B). These results indicate that better activation of NF-{kappa}B binding by cag PAI-positive strains is the underlying mechanism of the observed activation of the IL-12 p40 promoter by these bacterial strains. Considered together, these results indicate that H. pylori infection induces IL-12 p40 gene expression at least in part through the induced binding of p50 and p65 NF-{kappa}B family members to the NF-{kappa}B element of the IL-12 p40 promoter, and that this effect is dependent on cag PAI products.

NF-{kappa}B signal is essential for induction of IL-12 p40 expression by H. pylori in gastric epithelial cells. We next examined whether the H. pylori-mediated upregulation of IL-12 p40 gene expression involves signal transduction components in NF-{kappa}B activation. The activation of NF-{kappa}B requires the phosphorylation of two conserved serine residues of I{kappa}B{alpha} (Ser-32 and Ser-36) and I{kappa}Bβ (Ser-19 and Ser-23) within the NH2-terminal domain (28). Phosphorylation leads to the ubiquitination and 26S proteasome-mediated degradation of I{kappa}Bs, thereby releasing NF-{kappa}B from the complex to translocate to the nucleus and activate genes (28). The IKK complex, which is composed of two catalytic subunits (IKK{alpha} and IKKβ) and a regulatory subunit (IKK{gamma}), phosphorylates I{kappa}Bs (28). Previous studies indicated that members of the mitogen-activated protein (MAP) kinase kinase kinase family mediate the physiologic activation of IKK (64). These kinases include NIK (61). I{kappa}B{alpha} and I{kappa}Bβ dominant-interfering mutants and IKK{alpha}, IKKβ, and NIK kinase-deficient mutants were tested to determine their abilities to inhibit the H. pylori-mediated activation of the IL-12 p40-driven reporter gene. The expression of these various inhibitory mutants abolished H. pylori-induced IL-12 p40 expression (Fig. 6A). These data show that signaling components involved in the activation of NF-{kappa}B are necessary for the H. pylori activation of the IL-12 p40 promoter.


Figure 6
View larger version (39K):
[in this window]
[in a new window]

  		FIG. 6. NF-{kappa}B signal is essential for the activation of IL-12 p40 expression by H. pylori in gastric epithelial cells. (A) Functional effects of I{kappa}B{alpha} and I{kappa}Bβ dominant-interfering mutants and kinase-deficient IKK{alpha}, IKKβ, and NIK mutants on the H. pylori-induced activation of the IL-12 p40 promoter. MKN45 cells were transfected with the IL-12 p40 reporter construct and the indicated mutant plasmids or empty vector (pCMV4) and then infected with H. pylori ATCC 49503 for 6 h. The open bar indicates the luciferase (LUC) activity of the IL-12 p40 reporter construct and pCMV4 without H. pylori infection. All values first were calculated as the change (n-fold) in induction values relative to the basal level measured in uninfected cells. Data are means ± standard deviations from three independent experiments. (B) Bay 11-7082 and LLnL inhibit IL-12 p40 mRNA expression induced by H. pylori. MKN45 cells were pretreated with Bay 11-7082 (20 µM) or LLnL (20 µM) for 1 h prior to H. pylori infection and subsequently were infected with H. pylori ATCC 49503 for 6 h. IL-12 p40 mRNA expression on harvested cells was analyzed by RT-PCR. (C) Bay 11-7082 and LLnL inhibit H. pylori-induced NF-{kappa}B DNA binding. MKN45 cells were pretreated with Bay 11-7082 (20 µM) or LLnL (20 µM) for 1 h prior to H. pylori infection and subsequently were infected with H. pylori ATCC 49503 for 1 h. Nuclear extracts from harvested cells were analyzed for NF-{kappa}B. (D) Inhibitory effects of 17-AAG on H. pylori-induced IL-12 p40 expression. MKN45 cells were incubated with 1 µM 17-AAG for 16 h prior to infection with different densities (MOI) of H. pylori for 6 h. RT-PCR was performed to check for the effects of 17-AAG treatment on IL-12 p40 mRNA expression in H. pylori-infected MKN45 cells. M, size marker. (E) Attenuation of H. pylori-induced NF-{kappa}B DNA binding by 17-AAG treatment. MKN45 cells were treated with (+) 17-AAG or were left untreated (–) for 16 h prior to infection with H. pylori for 1 h. Nuclear extracts were isolated from MKN45 cells infected with H. pylori and analyzed for NF-{kappa}B. Representative results of three similar experiments are shown in each panel.

Because the activation of the IL-12 p40 promoter by H. pylori infection required the activation of NF-{kappa}B, we blocked NF-{kappa}B activation with Bay 11-7082, an inhibitor of I{kappa}B{alpha} phosphorylation (48), or LLnL, a proteasome inhibitor (25). The latter is known to inhibit the activation of NF-{kappa}B by blocking the degradation of the I{kappa}B{alpha} protein. Both Bay 11-7082 and LLnL markedly inhibited the H. pylori-induced NF-{kappa}B DNA binding and expression of IL-12 p40 mRNA (Fig. 6B and C).

Hsp90 also plays a critical role in the inflammatory response, and the requirement of Hsp90 for the activation of NF-{kappa}B has been suggested (7, 57). We evaluated the effect of the Hsp90 inhibitor 17-AAG on H. pylori-induced IL-12 p40 expression. MKN45 cells constitutively express Hsp90 protein, but H. pylori infection did not affect its expression (57). Pretreatment with 17-AAG completely inhibited H. pylori-induced IL-12 p40 expression (Fig. 6D). We next tested the direct influence of 17-AAG on the H. pylori-induced transcriptional activity of NF-{kappa}B using EMSA. Pretreatment with 17-AAG decreased the retardation of gel mobility through the inhibition of the DNA binding activity of the NF-{kappa}B complex, indicating the repression of the transcriptional activity of NF-{kappa}B (Fig. 6E). Of note, no differences in binding to the octamer motif on DNA were noted in the absence or presence of 17-AAG. These findings suggest that Hsp90 is involved in H. pylori-induced NF-{kappa}B-dependent IL-12 p40 signaling.

H. pylori increases IL-12 p40 mRNA expression in T cells. Because IL-12 staining was detected in lymphocytes of specimens from patients with H. pylori-positive gastritis, we investigated the induction of IL-12 p40 mRNA expression by H. pylori in Jurkat T cells. IL-12 p40 mRNA expression was induced in Jurkat cells within 1 h after infection with H. pylori (Fig. 7A). H. pylori infection also resulted in an increase in the activity of the IL-12 p40-driven reporter construct (Fig. 7B). To characterize the effect of H. pylori infection on human T cells, IL-12 p40 mRNA expression in CD4+ T cells in response to H. pylori was examined by RT-PCR. After infection for 2 h, the H. pylori-stimulated induction of IL-12 p40 mRNA expression in CD4+ T cells was observed, which is similar to the observations for Jurkat cells. Furthermore, Jurkat and CD4+ T cells cocultured with H. pylori during a 24-h period produced a low quantity of IL-12 p70, but the level was significantly higher than that of spontaneous IL-12 p70 production (Fig. 7C). However, IL-23 was not secreted (data not shown). Interestingly, the supernatant of H. pylori induced IL-12 p40 mRNA expression in Jurkat cells but not in MKN45 cells (Fig. 7D). This result indicates that direct interaction is not essential for the induction of IL-12 p40 mRNA expression in Jurkat cells. Furthermore, the induction of IL-12 p40 mRNA expression by an isogenic vacA mutant ({Delta}VacA) and cag PAI mutant ({Delta}cag PAI) was inhibited in Jurkat cells compared to expression by wild-type H. pylori 26695 (Fig. 7E). In contrast, the vacA mutant induced IL-12 p40 mRNA expression in MKN45 cells (Fig. 7E). H. pylori bacteria separated by a permeable membrane induced IL-12 p40 mRNA expression in Jurkat cells, although its level was less than that induced by H. pylori without a membrane (data not shown). These results suggest that both VacA in the culture supernatant and the cag PAI are essential for IL-12 p40 induction in Jurkat cells through direct interaction. In addition, the induction of IL-12 p40 expression was observed after challenge using the supernatant of H. pylori 26695 but not that of {Delta}VacA (data not shown). These observations indicate that both the cag PAI and VacA are responsible for the induction of IL-12 p40 mRNA expression in Jurkat cells.


Figure 7
View larger version (34K):
[in this window]
[in a new window]

  		FIG. 7. H. pylori-induced IL-12 p40 mRNA expression in T cells. (A) Total RNA was extracted from Jurkat cells and CD4+ T cells infected with H. pylori ATCC 49503 for the indicated times and used for RT-PCR (MOI, 10). M, size marker. (B) H. pylori activates the IL-12 p40 promoter in T cells. The IL-12 p40 reporter construct was transfected into Jurkat cells, and subsequently the cells were infected with H. pylori ATCC 49503 for 6 h (MOI, 20). The activity is expressed relative to that of cells transfected with the construct without further H. pylori infection, which was defined as 1. Data are means ± standard deviations from three independent experiments. **, P < 0.01, as determined by the Student t test. LUC, luciferase. (C) Increased secretion of IL-12 p70 into the supernatants of Jurkat and CD4+ T-cell cultures in response to H. pylori ATCC49503 infection at 24 h. IL-12 p70 concentrations in the supernatants were determined by ELISA. Data are means ± standard deviations from three experiments. *, P < 0.05; **, P < 0.01; both were determined by the Student t test. (D) Jurkat and MKN45 cells were incubated with the indicated concentrations of culture supernatants from H. pylori ATCC 49503 for 2 h. Note the supernatant-induced IL-12 p40 mRNA expression in Jurkat cells but not in MKN45 cells. (E) VacA and the cag PAI of H. pylori are required for the induction of IL-12 p40 expression in Jurkat cells, but VacA is not essential for the induction of IL-12 p40 in MKN45 cells. Total RNA was extracted from Jurkat and MKN45 cells infected with H. pylori (wild-type [WT] strain 26695 or the isogenic mutants {Delta}VacA and {Delta}cag PAI) for 2 h and used for RT-PCR. Representative results from three similar experiments are shown in each panel.

VacA induces IL-12 p40 mRNA expression and NF-{kappa}B activation in Jurkat cells. Because the induction of IL-12 p40 mRNA expression by the isogenic vacA mutant was inhibited in Jurkat cells compared to that of the wild-type strain, we next examined IL-12 p40 mRNA expression in Jurkat cells stimulated with VacA protein purified from H. pylori ATCC 49503. The overexpression of IL-12 p40 mRNA was observed in Jurkat cells (Fig. 8A). In contrast, no VacA-induced IL-12 p40 expression was observed in MKN45 cells, implying that VacA-induced IL-12 p40 expression is limited to certain cell types. To determine whether VacA could activate NF-{kappa}B signals in Jurkat cells, immunoblot analysis was performed using cell lysates after stimulation with VacA. The stimulation of Jurkat cells with VacA increased I{kappa}B{alpha} phosphorylation in a time-dependent manner (Fig. 8B).


Figure 8
View larger version (41K):
[in this window]
[in a new window]

  		FIG. 8. VacA-induced IL-12 p40 mRNA expression in T cells. (A) Dynamics of VacA-induced IL-12 p40 mRNA expression. Total RNA was extracted from the indicated cells that had been treated with VacA (20 µg/ml) for the indicated times and used for RT-PCR. M, size marker. (B) Jurkat cells were incubated with VacA for the indicated times. Cell lysates were prepared at the indicated incubation times and subjected to immunoblotting with the indicated antibodies. (C) Effects of PI3K and p38 MAP kinase inhibitors on VacA-mediated IL-12 p40 expression in Jurkat cells. Cells were pretreated with LY294002 (6.25 µM) or SB203580 (6.25 µM) for 1 h, followed by VacA treatment for 2 h, and then IL-12 p40 mRNA expression was analyzed by RT-PCR. Representative results from three similar experiments are shown in each panel.

We further investigated the roles of p38 MAP kinase and PI3K/Akt in VacA-induced IL-12 p40 expression in T cells. p38 MAP kinase is a family of serine/threonine kinases that form an integral component of proinflammatory signaling cascades in various cell types (31). Blocking p38 with specific inhibitors diminishes NF-{kappa}B-driven transcriptional activity and attenuates the expression of NF-{kappa}B target genes (3, 60). Previous studies showed that VacA induced the activation of p38 in gastric adenocarcinoma cell line AZ-521 and monocytic cell line U937 (20, 21). Accordingly, we examined whether VacA activates p38 in Jurkat cells. The phosphorylation of p38 was evident after a 10-min induction with VacA (Fig. 8B). There was no significant change in total p38 protein levels in VacA-treated Jurkat cells. Recent evidence suggests that the PI3K/Akt pathway also modulates the NF-{kappa}B signaling pathway (27). Therefore, Akt activation was checked with antibodies that specifically recognize phosphorylated Akt. As shown in Fig. 8B, VacA treatment increased phosphorylated Akt levels in a time-dependent manner. A p38 MAP kinase inhibitor (SB203580) and a PI3K inhibitor (LY294002) attenuated VacA-induced IL-12 p40 expression (Fig. 8C). These findings suggest that VacA activates p38 MAP kinase and PI3K/Akt and ultimately induces IL-12 p40 expression in T cells.


arrow
DISCUSSION
 
During H. pylori infection, there is a pronounced specific acquired immune response, which is characterized by the generation of antibodies and the differentiation and activation of effector T cells. Although the latter includes both Th1 and Th2 components, mucosal cytokine profiles imply Th1 predominance (15, 29), and the number of cells producing IFN-{gamma}, the key Th1 cytokine, in the H. pylori-infected gastric mucosa correlates with the severity of gastritis (33). IL-12 is supposed to be one of the major Th1-inducing factors in H. pylori-colonized gastric mucosa (47). It is produced primarily by antigen-presenting cells and exerts immunoregulatory effects on T and natural killer cells (58). However, the cellular source of IL-12 has not been investigated in the H. pylori-infected gastric mucosa. We found that IL-12 and IL-23 protein levels were markedly upregulated in gastric epithelial cells, lymphocytes, and macrophages in H. pylori-infected gastritis compared to levels for normal controls. Our present data clearly show that H. pylori induces IL-12 p40 mRNA expression in gastric epithelial cells and T cells.

The regulation of intracellular events leading to successful IL-23 p19/IL-12 p40 heterodimerization and IL-23 production are not well understood. IL-12 p70, but not IL-23, was secreted into the media of MKN45, Jurkat, and CD4+ T cells cocultured with H. pylori. Furthermore, it has been reported that IL-12 p40, but not IL-23, was produced in the activated monocytes (16). These discrepancies suggest the presence of an additional intracellular regulating mechanism driving the successful p19/p40 heterodimerization and IL-23 production.

We demonstrated that the expression of IL-12 p40 mRNA is further upregulated in response to H. pylori when there is stimulation by the proinflammatory cytokines IL-1{alpha} and TNF-{alpha}. Although IL-12 p70 was secreted into the media of MKN45 cells cocultured with H. pylori, the amount was small. In contrast, IL-12 p70 protein was clearly detected in inflamed H. pylori gastritis tissues. Importantly, these studies indicate that in the presence of proinflammatory cytokines, H. pylori can induce an amount of IL-12 sufficient to induce the Th1 cell response. Thus, the induction of IL-12 p40 expression by gastric epithelial cells upon interaction with H. pylori might be mediated through the induction of the proinflammatory cytokines IL-1{alpha} and TNF-{alpha} from H. pylori-activated macrophages or other cells. IL-23 production in H. pylori-infected gastritis also might be mediated through a similar mechanism.

H. pylori-induced gastritis is triggered primarily by H. pylori attaching to gastric epithelial cells (36). Once attached, it injects effector molecules into gastric epithelial cells or the lamina propria via a type IV secretion system. The products of cag PAI genes are supposed to form a type IV secretion system (2). H. pylori is considered noninvasive and to rarely infiltrate the gastric mucosa, even though there is an active Th1 immune response in the lamina propria of the H. pylori-infected stomach (55). However, Ito et al. (24) suggested that H. pylori-induced gastric epithelial damage allows the bacteria to invade the lamina propria and reach the gastric lymph nodes, which could result in chronic stimulation of the immune system.

The regulation of IL-12 p40 is fulfilled primarily at the transcription level and likely is controlled by regulatory elements in the promoter region that can influence the transcriptional activity of the gene. The promoter of the IL-12 p40 gene contains multiple response elements that act as protein binding sites. For instance, NF-{kappa}B and Ets2 are the two most important transcription factors in IL-12 expression regulation; they bind to the –116/–107 and –211/–206 regions, respectively (14, 34). It has been reported that C/EBPβ increases IL-12 gene transcription by interacting with the –80/–74 region of the promoter (49). Moreover, Sp1 and AP-1 were found to contribute equally to the regulation of IL-12 expression (10). In the present study, we demonstrated that the H. pylori challenge of gastric epithelial cells and T cells induces NF-{kappa}B activation, and that this event plays a critical role in the induction of IL-12 p40. H. pylori induces IL-12 p40 expression in T cells even without direct interaction with the cell surface and does not always require the presence of the cag PAI. There is virtually no infiltration of T cells in the mucosal layer in the absence of gastritis. However, once gastritis develops, numerous T cells infiltrate the mucosa (45). Our hypothesis is that in H. pylori infection, initially a small number of organisms come in direct contact with epithelial cells, activate NF-{kappa}B, and induce IL-12 p40. This step requires the cag PAI. However, once T cells infiltrate the mucosal layer, H. pylori is able to activate NF-{kappa}B without direct contact, independently of the cag PAI. This step amplifies the Th1 response in the gastric mucosa. It is interesting that the time to reach the maximal levels of IL-12 p40 mRNA expression in T cells was earlier than that in gastric epithelial cells. The influence of T cells on IL-12 p40 expression may be limited at a relatively early phase after infection.

VacA, a protein toxin produced by H. pylori, has multiple effects on susceptible cells (e.g., epithelial and lymphatic cells), including vacuolation with alterations of endolysosomal function, mitochondrial damage, and the inhibition of T-cell proliferation (5, 12, 18). These different effects of VacA appear to result from the activation of different signal transduction pathways. Interestingly, in T cells we found that VacA enhanced IL-12 p40 expression via NF-{kappa}B, p38 MAP kinase, and PI3K/Akt activation. p38 activates not only NF-{kappa}B (3, 60) but also ATF-2 or CREB, which can bind to the AP-1 region in the promoter. In addition to the NF-{kappa}B site of the IL-12 p40 promoter, the AP-1 site also may be a functionally critical site in T cells. Interestingly, VacA-induced IL-12 p40 expression was not observed in gastric epithelial cells. Three cell surface proteins on epithelial cells have been implicated so far as specific receptors for VacA. These include the epidermal growth factor receptor (52) as well as receptor-like tyrosine phosphatase {alpha} (62) and β (63). Recently, the β2 (CD18) integrin subunit was identified as a leukocyte-specific receptor for VacA on human T cells (53). Defective CD18 expression may be responsible for the lack of induction of IL-12 p40 expression by VacA in the epithelial cells.

In this study, we demonstrated the involvement of NIK and IKKs in the induction of IL-12 p40 expression. We also investigated the role of Hsp90 and found it plays a role in H. pylori-induced NF-{kappa}B activation.

In conclusion, we have shown in the present study that the mechanism of H. pylori-mediated IL-12 p40 expression is different in gastric epithelial cells and T cells. IL-12 p40 expression is induced through a cag PAI-dependent NF-{kappa}B pathway in gastric epithelial cells but through cag PAI- and VacA-dependent NF-{kappa}B pathways in T cells. Thus, the host response to H. pylori infection might involve VacA in addition to the cag PAI, leading to the Th1 response.


arrow
ACKNOWLEDGMENTS
 
We thank D. W. Ballard for providing the I{kappa}B{alpha} and I{kappa}Bβ dominant-negative mutants and R. Geleziunas for providing the NIK, IKK{alpha}, and IKKβ dominant-negative mutants.

This study was supported in part by grants-in-aid for scientific research (C) 19591123 to N.M. from the Japan Society for the Promotion of Science; scientific research on priority areas 20012044 to N.M. from the Ministry of Education, Culture, Sports, Science and Technology; and the Takeda Science Foundation.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan. Phone: 81-98-895-1130. Fax: 81-98-895-1410. E-mail: n-mori{at}med.u-ryukyu.ac.jp Back

{triangledown} Published ahead of print on 29 January 2009. Back

Editor: S. R. Blanke


arrow
REFERENCES
 
    1
  1. Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Bukanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:37-53.[CrossRef][Medline]
    2. 2
  2. Baldari, C. T., A. Lanzavecchia, and J. L. Telford. 2005. Immune subversion by Helicobacter pylori. Trends Immunol. 26:199-207.[CrossRef][Medline]
    3. 3
  3. Bhat, N. R., D. L. Feinstein, Q. Shen, and A. N. Bhat. 2002. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells: roles of nuclear factors, nuclear factor {kappa}B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-β, and activating transcription factor-2. J. Biol. Chem. 277:29584-29592.[Abstract/Free Full Text]
    4. 4
  4. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.[Abstract/Free Full Text]
    5. 5
  5. Boncristiano, M., S. R. Paccani, S. Barone, C. Ulivieri, L. Patrussi, D. Ilver, A. Amedei, M. M. D'Elios, J. L. Telford, and C. T. Baldari. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198:1887-1897.[Abstract/Free Full Text]
    6. 6
  6. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in I{kappa}B{alpha} to multiple pathways for NF-{kappa}B activation. Mol. Cell. Biol. 15:2809-2818.[Abstract]
    7. 7
  7. Broemer, M., D. Krappmann, and C. Scheidereit. 2004. Requirement of Hsp90 activity for I{kappa}B kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-{kappa}B activation. Oncogene 23:5378-5386.[CrossRef][Medline]
    8. 8
  8. Brunda, M. J. 1994. Interleukin-12. J. Leukoc. Biol. 55:280-288.[Abstract]
    9. 9
  9. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovski, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.[Abstract/Free Full Text]
    10. 10
  10. Chambers, K. A., R. J. Parks, and J. B. Angel. 2004. Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells. Clin. Exp. Immunol. 137:329-340.[CrossRef][Medline]
    11. 11
  11. Covacci, A., J. L. Telford, G. Del Giudice, J. Parsonnet, and R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284:1328-1333.[Abstract/Free Full Text]
    12. 12
  12. Cover, T. L., and S. R. Blanke. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3:320-332.[CrossRef][Medline]
    13. 13
  13. Crabtree, J. E., J. D. Taylor, J. I. Wyatt, R. V. Heatley, T. M. Shallcross, D. S. Tompkins, and B. J. Rathbone. 1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-335.[CrossRef][Medline]
    14. 14
  14. D'Ambrosio, D., M. Cippitelli, M. G. Cocciolo, D. Mazzeo, P. Di Lucia, R. Lang, F. Sinigaglia, and P. Panina-Bordignon. 1998. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-{kappa}B downregulation in transcriptional repression of the p40 gene. J. Clin. Investig. 101:252-262.[Medline]
    15. 15
  15. D'Elios, M. M., M. Manghetti, M. De Carli, F. Costa, C. T. Baldari, D. Burroni, J. L. Telford, S. Romagnani, and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967.[Abstract]
    16. 16
  16. Dobreva, Z. G., S. A. Stanilova, and L. D. Miteva. 2008. Differences in the inducible gene expression and protein production of IL-12p40, IL-12p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine 43:76-82.[CrossRef][Medline]
    17. 17
  17. Foryst-Ludwig, A., and M. Naumann. 2000. p21-activated kinase 1 activates the nuclear factor {kappa}B (NF-{kappa}B)-inducing kinase-I{kappa}B kinases NF-{kappa}B pathway and proinflammatory cytokines in Helicobacter pylori infection. J. Biol. Chem. 275:39779-39785.[Abstract/Free Full Text]
    18. 18
  18. Gebert, B., W. Fischer, E. Weiss, R. Hoffmann, and R. Haas. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102.[Abstract/Free Full Text]
    19. 19
  19. Geleziunas, R., S. Ferrell, X. Lin, Y. Mu, E. T. Cunningham, Jr., M. Grant, M. A. Connelly, J. E. Hambor, K. B. Marcu, and W. C. Greene. 1998. Human T-cell leukemia virus type 1 Tax induction of NF-{kappa}B involves activation of the I{kappa}B kinase {alpha} (IKK{alpha}) and IKKβ cellular kinases. Mol. Cell. Biol. 18:5157-5165.[Abstract/Free Full Text]
    20. 20
  20. Hisatsune, J., E. Yamasaki, M. Nakayama, D. Shirasaka, H. Kurazono, Y. Katagata, H. Inoue, J. Han, J. Sap, K. Yahiro, J. Moss, and T. Hirayama. 2007. Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect. Immun. 75:4472-4481.[Abstract/Free Full Text]
    21. 21
  21. Hisatsune, J., M. Nakayama, H. Isomoto, H. Kurazono, N. Mukaida, A. K. Mukhopadhyay, T. Azuma, Y. Yamaoka, J. Sap, E. Yamasaki, K. Yahiro, J. Moss, and T. Hirayama. 2008. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-{kappa}B activation. J. Immunol. 180:5017-5027.[Abstract/Free Full Text]
    22. 22
  22. Höcker, M., and P. Hohenberger. 2003. Helicobacter pylori virulence factors-one part of a big picture. Lancet 362:1231-1233.[CrossRef][Medline]
    23. 23
  23. Houghton, J., and T. C. Wang. 2005. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128:1567-1578.[CrossRef][Medline]
    24. 24
  24. Ito, T., D. Kobayashi, K. Uchida, T. Takemura, S. Nagaoka, I. Kobayashi, T. Yokoyama, I. Ishige, Y. Ishige, N. Ishida, A. Furukawa, H. Muraoka, S. Ikeda, M. Sekine, N. Ando, Y. Suzuki, T. Yamada, T. Suzuki, and Y. Eishi. 2008. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab. Investig. 88:664-681.[CrossRef][Medline]
    25. 25
  25. Jeremias, I., C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K. M. Debatin. 1998. Inhibition of nuclear factor {kappa}B activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624-4631.[Abstract/Free Full Text]
    26. 26
  26. Kalia, N., K. D. Bardhan, J. C. Atherton, and N. J. Brown. 2002. Toxigenic Helicobacter pylori induces changes in the gastric mucosal microcirculation in rats. Gut 51:641-647.[Abstract/Free Full Text]
    27. 27
  27. Kammanadiminti, S. J., I. Dey, and K. Chadee. 2007. Induction of monocyte chemotactic protein 1 in colonic epithelial cells by Entamoeba histolytica is mediated via the phosphatidylinositol 3-kinase/p65 pathway. Infect. Immun. 75:1765-1770.[Abstract/Free Full Text]
    28. 28
  28. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-{kappa}B activity. Annu. Rev. Immunol. 18:621-663.[CrossRef][Medline]
    29. 29
  29. Karttunen, R., T. Karttunen, H. P. Ekre, and T. T. MacDonald. 1995. Interferon {gamma} and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341-345.[Abstract/Free Full Text]
    30. 30
  30. Kodama, K., T. Fujioka, A. Ito, R. Kodama, and M. Nasu. 1998. Toxigenicity of Helicobacter pylori isolates possessing cagA gene and vacuolating cytotoxin. J. Gastroenterol. 33(Suppl. 10):14-17.[CrossRef][Medline]
    31. 31
  31. Kumar, S., J. Boehm, and J. C. Lee. 2003. p38 MAP kinase: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2:717-726.[CrossRef][Medline]
    32. 32
  32. Lankford, C. S. R., and D. M. Frucht. 2003. A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 73:49-56.[Abstract/Free Full Text]
    33. 33
  33. Lehmann, F. S., L. Terracciano, I. Carena, C. Baeriswyl, J. Drewe, L. Tornillo, G. De Libero, and C. Beglinger. 2002. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G481-G488.[Abstract/Free Full Text]
    34. 34
  34. Ma, X., M. Neurath, G. Gri, and G. Trinchieri. 1997. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 272:10389-10395.[Abstract/Free Full Text]
    35. 35
  35. Maeda, S., H. Yoshida, K. Ogura, Y. Mitsuno, Y. Hirata, Y. Yamaji, M. Akanuma, Y. Shiratori, and M. Omata. 2000. H. pylori activates NF-{kappa}B through a signaling pathway involving I{kappa}B kinases, NF-{kappa}B-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119:97-108.[CrossRef][Medline]
    36. 36
  36. Marshall, B. 2002. Helicobacter pylori: 20 years on. Clin. Med. 2:147-152.[CrossRef][Medline]
    37. 37
  37. McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard. 1996. Inactivation of I{kappa}Bβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-{kappa}B. Mol. Cell. Biol. 16:2083-2090.[Abstract]
    38. 38
  38. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172-2179.[Abstract]
    39. 39
  39. Ménard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.[Abstract/Free Full Text]
    40. 40
  40. Montecucco, C., and M. de Bernard. 2003. Immunosuppressive and proinflammatory activities of the VacA toxin of Helicobacter pylori. J. Exp. Med. 198:1767-1771.[Free Full Text]
    41. 41
  41. Mori, N., M. Fujii, S. Ikeda, Y. Yamada, M. Tomonaga, D. W. Ballard, and N. Yamamoto. 1999. Constitutive activation of NF-{kappa}B in primary adult T-cell leukemia cells. Blood 93:2360-2368.[Abstract/Free Full Text]
    42. 42
  42. Moss, S. F., and S. Sood. 2003. Helicobacter pylori. Curr. Opin. Infect. Dis. 16:445-451.[CrossRef][Medline]
    43. 43
  43. Nakayama, M., M. Kimura, A. Wada, K. Yahiro, K. Ogushi, T. Niidome, A. Fujikawa, D. Shirasaka, N. Aoyama, H. Kurazono, M. Noda, J. Moss, and T. Hirayama. 2004. Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells. J. Biol. Chem. 279:7024-7028.[Abstract/Free Full Text]
    44. 44
  44. Noach, L. A., N. B. Bosma, J. Jansen, F. J. Hoek, S. J. van Deventer, and G. N. Tytgat. 1994. Mucosal tumor necrosis factor-{alpha}, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 29:425-429.[Medline]
    45. 45
  45. Papadimitriou, C. S., E. E. Ioachim-Velogianni, E. B. Tsianos, and H. M. Moutsopoulos. 1988. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch. A Pathol. Anat. Histopathol. 413:197-204.[CrossRef][Medline]
    46. 46
  46. Peek, R. M., Jr., and M. J. Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.[CrossRef][Medline]
    47. 47
  47. Pellicanò, A., L. Sebkova, G. Monteleone, G. Guarnieri, M. Imeneo, F. Pallone, and F. Luzza. 2007. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect. Immun. 75:1738-1744.[Abstract/Free Full Text]
    48. 48
  48. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced I{kappa}B{alpha} phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096-21103.[Abstract/Free Full Text]
    49. 49
  49. Plevy, S. E., J. H. Gemberling, S. Hsu, A. J. Dorner, and S. T. Smale. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:4572-4588.[Abstract]
    50. 50
  50. Robinson, K., R. H. Argent, and J. C. Atherton. 2007. The inflammatory and immune response to Helicobacter pylori infection. Best Pract. Res. Clin. Gastroenterol. 21:237-259.[CrossRef][Medline]
    51. 51
  51. Rudi, J., C. Kolb, M. Maiwald, D. Kuck, A. Sieg, P. R. Galle, and W. Stremmel. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36:944-948.[Abstract/Free Full Text]
    52. 52
  52. Seto, K., Y. Hayashi-Kuwabara, T. Yoneta, H. Suda, and H. Tamaki. 1998. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by the EGF receptor in HeLa cells. FEBS Lett. 431:347-350.[CrossRef][Medline]
    53. 53
  53. Sewald, X., B. Gebert-Vogl, S. Prassl, I. Barwig, E. Weiss, M. Fabbri, R. Osicka, M. Schiemann, D. H. Busch, M. Semmrich, B. Holzmann, P. Sebo, and R. Haas. 2008. Integrin subunit CD18 is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe. 3:20-29.[CrossRef][Medline]
    54. 54
  54. Sharma, S. A., M. K. Tummuru, M. J. Blaser, and L. D. Kerr. 1998. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-{kappa}B in gastric epithelial cells. J. Immunol. 160:2401-2407.[Abstract/Free Full Text]
    55. 55
  55. Suerbaum, S., and P. Michetti. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.[Free Full Text]
    56. 56
  56. Supajatura, V., H. Ushio, A. Wada, K. Yahiro, K. Okumura, H. Ogawa, T. Hirayama, and C. Ra. 2002. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 168:2603-2607.[Abstract/Free Full Text]
    57. 57
  57. Tomimori, K., E, Uema, H. Teruya, C. Ishikawa, T. Okudaira, M. Senba, K. Yamamoto, T. Matsuyama, F. Kinjo, J. Fujita, and N. Mori. 2007. Helicobacter pylori induces CCL20 expression. Infect. Immun. 75:5223-5232.[Abstract/Free Full Text]
    58. 58
  58. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.[CrossRef][Medline]
    59. 59
  59. Tummuru, M. K. R., S. A. Sharma, and M. J. Blaser. 1995. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18:867-876.[CrossRef][Medline]
    60. 60
  60. Vanden Berghe, W., S. Plaisance, E. Boone, K. De Bosscher, M. L. Schmitz, W. Fiers, and G. Haegeman. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-{kappa}B p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:3285-3290.[Abstract/Free Full Text]
    61. 61
  61. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. I{kappa}B kinase-β: NF-{kappa}B activation and complex formation with I{kappa}B kinase-{alpha} and NIK. Science 278:866-869.[Abstract/Free Full Text]
    62. 62
  62. Yahiro, K., A. Wada, M. Nakayama, T. Kimura, K. Ogushi, T. Niidome, H. Aoyagi, K. Yoshino, K. Yonezawa, J. Moss, and T. Hirayama. 2003. Protein-tyrosine phosphatase {alpha}, RPTP{alpha}, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 278:19183-19189.[Abstract/Free Full Text]
    63. 63
  63. Yahiro, K., T. Niidome, M. Kimura, T. Hatakeyama, H. Aoyagi, H. Kurazono, K. Imagawa, A. Wada, J. Moss, and T. Hirayama. 1999. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase β. J. Biol. Chem. 274:36693-36699.[Abstract/Free Full Text]
    64. 64
  64. Zandi, E., and M. Karin. 1999. Bridging the gap: composition, regulation, and physiological function of the I{kappa}B kinase complex. Mol. Cell. Biol. 19:4547-4551.[Free Full Text]

Infection and Immunity, April 2009, p. 1337-1348, Vol. 77, No. 4
0019-9567/09/$08.00+0     doi:10.1128/IAI.01456-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeshima, E.
Right arrow Articles by Mori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeshima, E.
Right arrow Articles by Mori, N.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»